PE
ALT icon

Point72 Europe’s Altimmune ALT Stock Holding History

Point72 Europe’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$20.7K Buy
+5,484
New +$21.2K ﹤0.01% 468

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Europe's ALT Position: Q3 2025 in Review

Point72 Europe opened a new position in Altimmune (ALT) in Q3 2025: 5,484 shares worth $20.7K. The stake represents ﹤0.01% of the portfolio and ranks #468 among its holdings.

158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Point72 Europe held 5,484 shares of Altimmune worth $20.7K as of Q3 2025.
  • Altimmune was a new Point72 Europe position in Q3 2025.
  • Altimmune made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #468 holding.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.